<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00409604</url>
  </required_header>
  <id_info>
    <org_study_id>CS1017-001</org_study_id>
    <nct_id>NCT00409604</nct_id>
  </id_info>
  <brief_title>PROTECT : Pacing to Protect Heart for Damage From Blocked Heart Vessel and From Re-opening Blocked Vessel(s)</brief_title>
  <official_title>Clinical Evaluation of Pacing During the Onset of Revascularization / Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guidant Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guidant Corporation</source>
  <brief_summary>
    <textblock>
      To determine whether the application of ventricular pacing can protect the human heart from
      damage resulting from a myocardial infarction
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine whether the application of ventricular pacing can protect the human heart from
      damage resulting from a myocardial infarction
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infarct size (area under the curve of creatine kinase) at baseline compared with MRI at 4 months and at 12 months</measure>
    <time_frame>4 &amp; 12 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard PCI procedure + pacing post conditioning</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard PCI procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Temporary RV VVI pacing</intervention_name>
    <description>temporary pacing at the onset of revascularisation</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of acute myocardial infarction, requiring PCI within 2 to 6 hours
             following symptoms

          -  Total occlusion of a coronary artery with reference vessel diameter &gt;or= 3mm

        Exclusion Criteria:

          -  Thrombolitics

          -  Severe bradycardia requiring cardiac pacing

          -  Previous PCI or CABG

          -  Recent stroke or CV surgery

          -  Recent major surgery or trauma

          -  Clinical and hemodynamic unstability

          -  Implanted CRM device

          -  Evidence of previous MI

          -  Diabetes using rosiglitazone or other fibrates

          -  Permanent AF

          -  Mechanical tricuspid valve

          -  Pregnancy

          -  Exclusion for MRI

          -  Incapability of participating in exercise test
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>JOhannes Waltenberger, Prof.Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Maastricht (azM), P. Debyelaan 25, 6202 AZ Maastricht, The Netherlands</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Maastricht (azM)</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2006</study_first_submitted>
  <study_first_submitted_qc>December 8, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2006</study_first_posted>
  <last_update_submitted>August 30, 2010</last_update_submitted>
  <last_update_submitted_qc>August 30, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2010</last_update_posted>
  <responsible_party>
    <name_title>Racho Strauven</name_title>
    <organization>Guidant Europe</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

